Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CAB Payments appoints James Hopkinson as CFO

(Sharecast News) - CAB Payments said on Wednesday that James Hopkinson has been appointed to the role of chief financial officer. The company, which specialises in business-to-business cross-border payments and foreign exchange, said Hopkinson is a "highly accomplished senior finance executive bringing strong broad based and highly relevant experience to CAB".

He has worked for over 25 years across global banks and emerging markets, FX and payments and also has experience driving business transformations.

CAB said Hopkinson built his career at Standard Chartered, where he spent almost 20 years across multiple geographies including Africa, Hong Kong, India, Singapore, Qatar and the UK. Latterly, he held senior roles including Global CFO of retail banking.

He was most recently Group CFO and executive director of Metro Bank, which he joined in July 2022 and where he helped to execute the turnaround plan. Prior to that, Hopkinson was Group CFO of ClearBank.

Chair Ann Cairns said: "I am delighted to welcome James to CAB Payments. He brings a wealth of relevant experience with deep sector expertise and is a highly suitable partner for Neeraj and the rest of the senior leadership team to take the business forward during its transformation. The board is looking forward to working with him."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.